Particle.news

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

IISc researchers say the effect stems from low Tropomyosin 2.1 in tumour cells, and they are moving to advanced preclinical validation.

Overview

  • The study, reported July 2–3 by researchers at the Indian Institute of Science and MS Ramaiah Medical College, tested moderate low-frequency ultrasound on patient-derived oral tumour samples and 3D co-culture models.
  • Ultrasound exposure produced selective cancer-cell death while largely sparing healthy oral epithelial cells under the conditions tested.
  • The team linked the sensitivity to reduced levels of Tropomyosin 2.1, a mechanosensory protein that normally helps cells sense and withstand mechanical stress.
  • In 3D models ultrasound also reduced cancer cell migration and invasion and disrupted the dense, capsule-like barrier formed by tumour-associated cells that can block drugs and immune cells.
  • Researchers plan further work in advanced preclinical models and to study combinations with existing therapies before any animal or human trials, leaving the approach at an early translational stage.